Human-IgG-Neutralizing Monoclonal Antibodies Block the SARS-CoV-2 Infection

Jinkai Wan(Massachusetts General Hospital), Fei Lan(Shanghai Medical College of Fudan University), Jingyu Jiao(Zhejiang Hisun Pharmaceutical (China)), Bowen Rong(Fudan University), Xiangxi Wang(Peking University), Kun Chen(Sun Yat-sen University), Chenxi He(Chongqing Public Health Medical Center), Longfei Ding(Shanghai Public Health Clinical Center), Cheng Li(First Affiliated Hospital of Zhengzhou University), Shenghui Xing(Fudan University), Tianlei Ying(Shanghai Medical College of Fudan University), Zhangzhao Gao(Zhejiang Hisun Pharmaceutical (China)), Xiaoyan Zhang(Fujian Medical University), Haibin Wang(Beijing Center for Disease Prevention and Control), Lei Nie(Shandong University), Youhua Xie(Shanghai Medical College of Fudan University), Chenjian Gu(Washington University in St. Louis), Yongheng Wang(Chinese Academy of Sciences), Chen Zhao(Jiangsu Province Hospital), Yanan Lu(Henan Agricultural University), Yanling Wu(Shanghai Medical College of Fudan University), Songhua Yuan(Shanghai Medical College of Fudan University), Dandan Zhu, Jianqing Xu(Weifang Medical University), Siqing Wang(Fudan University), Chengli Qiu(Shanghai Public Health Clinical Center)
Cell Reports
July 1, 2020
Cited by 164


Related Papers